Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4602278
Author(s) Sanvee, Gerda M.; Bouitbir, Jamal; Krähenbühl, Stephan
Author(s) at UniBasel Bouitbir, Jamal
Sanvee, Mawududzi Gerda
Krähenbühl, Stephan
Year 2019
Title Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
Journal Scientific reports
Volume 9
Number 1
Pages / Article-Number 7409
Abstract Simvastatin is an inhibitor of the 3-hydroxy-3-methylglutaryl-CoA reductase used for decreasing low density lipoprotein (LDL)-cholesterol in patients. It is well-tolerated but can cause myopathy. Our aims were to enlarge our knowledge regarding mechanisms and effects of insulin on simvastatin-associated myotoxicity in C2C12 myotubes. Simvastatin (10 µM) reduced membrane integrity and ATP content in myotubes treated for 24 hours, which could be prevented and partially reversed concentration- and time-dependently by insulin. Furthermore, simvastatin impaired the phosphorylation of Akt (Protein Kinase B) mainly at Ser473 and less at Thr308, indicating impaired activity of the mammalian Target of Rapamycin Complex 2 (mTORC2). Impaired activation of Akt increased mRNA expression of the muscle atrophy F-Box (MAFbx), decreased activation of the mammalian Target of Rapamycin Complex 1 (mTORC1) and stimulated apoptosis by impairing the Ser9 phosphorylation of glycogen synthase kinase 3β. Decreased phosphorylation of Akt at both phosphorylation sites and of downstream substrates as well as apoptosis were prevented concentration-dependently by insulin. In addition, simvastatin caused accumulation of the insulin receptor β-chain in the endoplasmic reticulum (ER) and increased cleavage of procaspase-12, indicating ER stress. Insulin reduced the expression of the insulin receptor β-chain but increased procaspase-12 activation in the presence of simvastatin. In conclusion, simvastatin impaired activation of Akt Ser473 most likely as a consequence of reduced activity of mTORC2. Insulin could prevent the effects of simvastatin on the insulin signaling pathway and on apoptosis, but not on the endoplasmic reticulum (ER) stress induction.
Publisher Nature Publishing Group
ISSN/ISBN 2045-2322
URL https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31092879/
edoc-URL https://edoc.unibas.ch/78264/
Full Text on edoc No
Digital Object Identifier DOI 10.1038/s41598-019-43938-5
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31092879
ISI-Number WOS:000468025300005
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.349 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
03/05/2024